NCT06291844

Brief Summary

Ocular injuries, a significant contributor to avoidable blindness globally, impact approximately 55 million individuals each year. Prompt initial treatment is vital for improving vision, yet the scarcity of skilled eye specialists often results in overcrowding at advanced medical centers. Moreover, the COVID-19 outbreak has introduced distinct factors into the management of ocular trauma. This research investigated the epidemiology of ocular injuries during the pandemic and offered observations on the distinctive hurdles and trends encountered.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 1, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 4, 2024

Completed
Last Updated

March 4, 2024

Status Verified

March 1, 2024

Enrollment Period

1.2 years

First QC Date

March 1, 2024

Last Update Submit

March 1, 2024

Conditions

Ophthalmological DisorderOcular InjuryCOVID-19

Outcome Measures

Primary Outcomes (1)

  • Ocular Trauma

    2 weeks

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Ocular trauma patients

You may qualify if:

  • Ocular Trauma Patients presenting between January 2021 to March 2022

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Ophthalmology, Prof. R. D. Kandou General Hospital - Faculty of Medicine, Sam Ratulangi University

Manado, North Sulawesi, Indonesia

Location

MeSH Terms

Conditions

Eye DiseasesEye InjuriesCOVID-19

Condition Hierarchy (Ancestors)

Facial InjuriesCraniocerebral TraumaTrauma, Nervous SystemNervous System DiseasesWounds and InjuriesPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vera Sumual, MD, PhD

Study Record Dates

First Submitted

March 1, 2024

First Posted

March 4, 2024

Study Start

January 1, 2021

Primary Completion

March 31, 2022

Study Completion

June 1, 2023

Last Updated

March 4, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations

ID(1)